• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

饮食对肠道微生物群、炎症和 2 型糖尿病的影响。对纯素玛莎 2 饮食的初步体验。

Influence of diet on gut microbiota, inflammation and type 2 diabetes mellitus. First experience with macrobiotic Ma-Pi 2 diet.

机构信息

University La Sapienza, Rome, Italy.

出版信息

Diabetes Metab Res Rev. 2014 Mar;30 Suppl 1:48-54. doi: 10.1002/dmrr.2518.

DOI:10.1002/dmrr.2518
PMID:24532292
Abstract

Type 2 diabetes mellitus (T2DM) is a complex disorder influenced by both genetic and environmental factors. Recent studies have suggested that an imbalance of the intestinal microbiota may be involved in the development of several human diseases, including obesity and T2DM. The main regulators of the intestinal microbiota are age, ethnicity, the immune system and diet. A high-fat diet may induce dysbiosis, which can result in a low-grade inflammatory state, obesity and other metabolic disorders. Adding prebiotics to the diet may reduce inflammation, endotoxaemia and cytokine levels as well as improving insulin resistance and glucose tolerance. The administration of prebiotics such as fermentable dietary fibres, promotes glucagon-like peptide 1 and peptide YY (anorexigenic) and decreases ghrelin (orexigenic). In a recent 21-day, intervention study in patients with T2DM, the effect of using the macrobiotic Ma-Pi 2 diet was investigated. Results suggested that it could induce a significant improvement in fasting blood glucose, plasma lipid fractions, plasma insulin and homeostasis. It is therefore possible that a diet rich in prebiotics and probiotics can play a role in T2DM management, probably due to positive intestinal microbiota modulation. However, this must be demonstrated by larger studies including randomized controlled trials that measure indicators of inflammation.

摘要

2 型糖尿病(T2DM)是一种受遗传和环境因素共同影响的复杂疾病。最近的研究表明,肠道微生物群的失衡可能与包括肥胖和 T2DM 在内的多种人类疾病的发生有关。肠道微生物群的主要调节剂是年龄、种族、免疫系统和饮食。高脂肪饮食可能会导致肠道微生物群失调,从而导致低度炎症状态、肥胖和其他代谢紊乱。在饮食中添加益生元可以降低炎症、内毒素血症和细胞因子水平,并改善胰岛素抵抗和葡萄糖耐量。添加可发酵膳食纤维等益生元可以促进胰高血糖素样肽 1 和肽 YY(厌食)的分泌,同时降低胃饥饿素(食欲)的分泌。在一项最近针对 T2DM 患者的为期 21 天的干预研究中,研究了采用宏量营养 Ma-Pi 2 饮食的效果。结果表明,它可以显著改善空腹血糖、血浆脂质成分、血浆胰岛素和血糖稳态。因此,富含益生元和益生菌的饮食可能在 T2DM 管理中发挥作用,这可能是由于对肠道微生物群的积极调节。然而,这必须通过包括测量炎症指标的随机对照试验在内的更大规模研究来证明。

相似文献

1
Influence of diet on gut microbiota, inflammation and type 2 diabetes mellitus. First experience with macrobiotic Ma-Pi 2 diet.饮食对肠道微生物群、炎症和 2 型糖尿病的影响。对纯素玛莎 2 饮食的初步体验。
Diabetes Metab Res Rev. 2014 Mar;30 Suppl 1:48-54. doi: 10.1002/dmrr.2518.
2
Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.肠道微生物群控制脂肪组织扩张、肠道屏障和葡萄糖代谢:对使用益生元的分子靶点和干预措施的新见解。
Benef Microbes. 2014 Mar;5(1):3-17. doi: 10.3920/BM2012.0065.
3
'The way to a man's heart is through his gut microbiota'--dietary pro- and prebiotics for the management of cardiovascular risk.“通往男人心的路是通过他的肠道微生物群”——用于管理心血管风险的饮食益生菌和益生元。
Proc Nutr Soc. 2014 May;73(2):172-85. doi: 10.1017/S0029665113003911. Epub 2014 Feb 4.
4
Gut microbiota in obesity and metabolic disorders.肥胖与代谢紊乱相关的肠道菌群。
Proc Nutr Soc. 2010 Aug;69(3):434-41. doi: 10.1017/S0029665110001813. Epub 2010 Jun 14.
5
Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance?肠道微生物群与肥胖、胰岛素抵抗和 2 型糖尿病的相互作用:肠道微生物群是否与胰岛素抵抗共同进化?
Curr Opin Clin Nutr Metab Care. 2011 Sep;14(5):483-90. doi: 10.1097/MCO.0b013e328348c06d.
6
Gut microbiota as a key player in triggering obesity, systemic inflammation and insulin resistance.肠道微生物群是引发肥胖、全身炎症和胰岛素抵抗的关键因素。
Rev Invest Clin. 2014 Sep-Oct;66(5):450-9.
7
Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury.肠道微生物群、肠道通透性、肥胖引起的炎症和肝损伤。
JPEN J Parenter Enteral Nutr. 2011 Sep;35(5 Suppl):14S-20S. doi: 10.1177/0148607111413772. Epub 2011 Aug 1.
8
Probiotics, prebiotics, energy balance, and obesity: mechanistic insights and therapeutic implications.益生菌、益生元、能量平衡与肥胖:作用机制与治疗意义
Gastroenterol Clin North Am. 2012 Dec;41(4):843-54. doi: 10.1016/j.gtc.2012.08.009.
9
[Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].[肠道微生物群的生理模式。肠道菌群失调在肥胖、胰岛素抵抗、糖尿病和代谢综合征中的作用]
Orv Hetil. 2016 Jan 3;157(1):13-22. doi: 10.1556/650.2015.30296.
10
Ma-Pi 2 macrobiotic diet and type 2 diabetes mellitus: pooled analysis of short-term intervention studies.麦皮 2 型养生饮食与 2 型糖尿病:短期干预研究的汇总分析。
Diabetes Metab Res Rev. 2014 Mar;30 Suppl 1:55-66. doi: 10.1002/dmrr.2519.

引用本文的文献

1
In Vitro and In Vivo Antihyperglycemic Effects of New Metabiotics from .来自……的新型代谢物的体外和体内降血糖作用
Life (Basel). 2023 Dec 30;14(1):68. doi: 10.3390/life14010068.
2
Microbiota Implications in Endocrine-Related Diseases: From Development to Novel Therapeutic Approaches.微生物群在内分泌相关疾病中的影响:从发育到新型治疗方法
Biomedicines. 2024 Jan 18;12(1):221. doi: 10.3390/biomedicines12010221.
3
The roles of dietary lipids and lipidomics in gut-brain axis in type 2 diabetes mellitus.膳食脂质和脂质组学在 2 型糖尿病的肠脑轴中的作用。
J Transl Med. 2023 Apr 2;21(1):240. doi: 10.1186/s12967-023-04088-5.
4
The Effect of Prebiotics and Oral Anti-Diabetic Agents on Gut Microbiome in Patients with Type 2 Diabetes: A Systematic Review and Network Meta-Analysis of Randomised Controlled Trials.益生菌和口服抗糖尿病药物对 2 型糖尿病患者肠道微生物组的影响:随机对照试验的系统评价和网络荟萃分析。
Nutrients. 2022 Dec 2;14(23):5139. doi: 10.3390/nu14235139.
5
Reshaping the Gut Microbiota Through Lifestyle Interventions in Women with PCOS: A Review.通过生活方式干预重塑多囊卵巢综合征女性的肠道微生物群:一项综述
Indian J Microbiol. 2022 Sep;62(3):351-363. doi: 10.1007/s12088-022-01019-8. Epub 2022 Apr 19.
6
The role of bacterial translocation in sepsis: a new target for therapy.细菌移位在脓毒症中的作用:一个新的治疗靶点。
Therap Adv Gastroenterol. 2022 May 9;15:17562848221094214. doi: 10.1177/17562848221094214. eCollection 2022.
7
Comparative Analysis of the Fecal Microbiota of Relict Gull () in Mu Us Desert (Hao Tongcha Nur) and Bojiang Haizi in Inner Mongolia, China.中国内蒙古毛乌素沙漠(郝同查淖尔)和泊江海子遗鸥粪便微生物群的比较分析
Front Vet Sci. 2022 Apr 6;9:860540. doi: 10.3389/fvets.2022.860540. eCollection 2022.
8
Analysis of the gut microbiota composition of myostatin mutant cattle prepared using CRISPR/Cas9.利用 CRISPR/Cas9 技术制备的肌肉生长抑制素基因突变牛的肠道微生物组成分析。
PLoS One. 2022 Mar 4;17(3):e0264849. doi: 10.1371/journal.pone.0264849. eCollection 2022.
9
Possible Benefits of for Obesity-Associated Gut Disorders.[具体内容]对肥胖相关肠道疾病的潜在益处。 (由于原文不完整,“Possible Benefits of”后面缺少具体内容,只能这样翻译大概意思 )
Front Pharmacol. 2021 Dec 2;12:740636. doi: 10.3389/fphar.2021.740636. eCollection 2021.
10
Gut Microbiota Regulation and Their Implication in the Development of Neurodegenerative Disease.肠道微生物群的调节及其在神经退行性疾病发展中的意义。
Microorganisms. 2021 Nov 2;9(11):2281. doi: 10.3390/microorganisms9112281.